| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-10 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.22 | 3e-06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |